Skillfully crafted cell lines for recombinant adeno-associated virus (AAV) production can substantially enhance vector purity and yield. These specialized cell lines could help to reduce manufacturing costs and environmental impact.
In this webinar, we explore a portfolio of engineered cell lines and their potential to transform the landscape of AAV production.
Join us to:
- Discover the impact of adopting ELEVECTA™ stable cell lines for AAV production, focusing on sustainability improvements and regulatory implications.
- Uncover how cell line engineering can tackle encapsidated host cell DNA (ehcDNA), a contaminant that current downstream processing can’t remove.
